Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.


Autoria(s): Leung Ki E.L.; Venetz J.P.; Meylan P.; Lamoth F.; Ruiz J.; Pascual M.
Data(s)

2008

Resumo

We analyzed data from all consecutive kidney transplant patients at our institution between April 2003 and October 2006. We found 15 cases of late-onset cytomegalovirus (CMV) infection, two of which developed concurrent post-transplant diabetes mellitus (PTDM). In these two cases, PTDM was transient and normal glucose tolerance was achieved after an eight-wk therapeutic course of oral valganciclovir. These findings suggest that CMV infection after organ transplantation may be associated with concurrent PTDM. The distinct causative relationship is yet to be determined.

Identificador

http://serval.unil.ch/?id=serval:BIB_11733DE83D93

isbn:1399-0012 (Electronic)

pmid:18339147

doi:10.1111/j.1399-0012.2007.00758.x

isiid:000253982000018

Idioma(s)

en

Fonte

Clinical Transplantation, vol. 22, no. 2, pp. 245-249

Palavras-Chave #Adult; Antiviral Agents/therapeutic use; Cytomegalovirus Infections/complications; Cytomegalovirus Infections/drug therapy; Diabetes Mellitus, Type 2/virology; Female; Ganciclovir/analogs & derivatives; Ganciclovir/therapeutic use; Humans; Kidney Transplantation/adverse effects; Male; Middle Aged; Postoperative Complications/virology
Tipo

info:eu-repo/semantics/article

article